131 related articles for article (PubMed ID: 16141678)
1. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis.
Matsuda K; Mikami Y; Takeda K; Fukuyama S; Egawa S; Sunamura M; Maruyama I; Matsuno S
Tohoku J Exp Med; 2005 Oct; 207(2):99-107. PubMed ID: 16141678
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in acute gastric damage and pancreatitis.
Dembiński A; Warzecha Z; Ceranowicz P; Dembiński M; Cieszkowski J; Pawlik WW; Konturek SJ; Tomaszewska R; Hładki W; Konturek PC
J Physiol Pharmacol; 2006 Nov; 57 Suppl 5():137-54. PubMed ID: 17218765
[TBL] [Abstract][Full Text] [Related]
4. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.
Gaskari SA; Liu H; D'Mello C; Kunos G; Lee SS
J Hepatol; 2015 Jun; 62(6):1272-7. PubMed ID: 25640062
[TBL] [Abstract][Full Text] [Related]
5. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
6. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
[TBL] [Abstract][Full Text] [Related]
7. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Moezi L; Gaskari SA; Liu H; Baik SK; Dehpour AR; Lee SS
Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
[TBL] [Abstract][Full Text] [Related]
8. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M
J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
10. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B
J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216
[TBL] [Abstract][Full Text] [Related]
11. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.
Muthian S; Rademacher DJ; Roelke CT; Gross GJ; Hillard CJ
Neuroscience; 2004; 129(3):743-50. PubMed ID: 15541895
[TBL] [Abstract][Full Text] [Related]
12. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats.
Resstel LB; Lisboa SF; Aguiar DC; Corrêa FM; Guimarães FS
Psychopharmacology (Berl); 2008 Jun; 198(3):405-11. PubMed ID: 18446325
[TBL] [Abstract][Full Text] [Related]
13. Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion.
Fernandez-Solari J; Prestifilippo JP; Ossola CA; Rettori V; Elverdin JC
Arch Oral Biol; 2010 Aug; 55(8):583-90. PubMed ID: 20542488
[TBL] [Abstract][Full Text] [Related]
14. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
15. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
17. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.
De Oliveira Alvares L; Genro BP; Diehl F; Quillfeldt JA
Neurobiol Learn Mem; 2008 Jul; 90(1):1-9. PubMed ID: 18342551
[TBL] [Abstract][Full Text] [Related]
18. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
Wagner JA; Varga K; Ellis EF; Rzigalinski BA; Martin BR; Kunos G
Nature; 1997 Dec; 390(6659):518-21. PubMed ID: 9394002
[TBL] [Abstract][Full Text] [Related]
19. CB
Dos Anjos-Garcia T; Ullah F; Falconi-Sobrinho LL; Coimbra NC
Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
[TBL] [Abstract][Full Text] [Related]
20. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain.
Guindon J; De Léan A; Beaulieu P
Pain; 2006 Mar; 121(1-2):85-93. PubMed ID: 16480822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
